As it stated in chickashanews
Why a Zika vaccine is a long way off
Why a Zika vaccine is a long way off
With your existing account from... {* loginWidget *}{* #socialRegistrationForm *} {* socialRegistration_firstName *} {* socialRegistration_lastName *} {* socialRegistration_emailAddress *} {* socialRegistration_displayName *} By clicking "Sign in", you confirm that you accept our terms of service and have read and understand privacy policy .{* /socialRegistrationForm *}We have sent a confirmation email to {* emailAddressData *}.Please check your email and click on the link to activate your account.
besides dailymail
Why we are nowhere near a Zika vaccine - despite millions of taxpayers' money spent
Why we are nowhere near a Zika vaccine - despite millions of taxpayers' money spent
Recent news articles have highlighted positive findings in experimental Zika virus pre-clinical vaccine studies in monkeys and described the start of two Zika virus vaccine trials in humans.These stories have spurred hopes that a Zika virus vaccine will be available to prevent this infection, and its secondary effects, such as abnormal fetal development.But, even with pre-clinical and early stage clinical trials underway, we still may not see a Zika vaccine licensed and approved for use in humans for years.
coupled with indiatimes
Sanofi gets $43 million U.S. funding to spur Zika vaccine development
Sanofi gets $43 million U.S. funding to spur Zika vaccine development
Sanofi SA said on Monday the U.S. Department of Health and Human Services approved $43.18 million in funding to accelerate the development of a Zika vaccine, as part of efforts to prevent the infection.The funding from the Biomedical Advanced Research and Development Authority (BARDA) will be used for mid-stage trials, expected to begin in the first half of 2018, and manufacturing, the French drugmaker said.Sanofi's vaccine unit, Sanofi Pasteur, said in February it intended to develop a Zika vaccine.The funding runs through June 2022, but if the data is positive, the contract includes an option for up to additional $130.45 million for late-stage trials necessary for eventual approval.Hundreds of thousands of people are estimated to have been infected with Zika in the Americas and parts of Asia since the virus was detected in Brazil early last year.Most have no symptoms or experience only a mild illness.However, the virus can penetrate the womb in pregnant women, causing a rare but crippling birth defect known as microcephaly.In adults, it has been linked to Guillain-Barre syndrome, a form of temporary paralysis.
by the same token on pulseheadlines
The U.S. gives Sanofi $43M for Zika vaccine development
The U.S. gives Sanofi $43M for Zika vaccine development
The Biomedical Advanced Research and Development Authority (BARDA) is giving Sanofi $43.18 million to fund the manufacture of a Zika vaccine.The U.S. funds will be used to create and produce an inactivated Zika vaccine for phase II development.Sanofi's vaccines global business unit, Sanofi Pasteur, announced Monday BARDA is going to fund their phase II trials to develop a vaccine to prevent Zika virus.
No comments:
Post a Comment